Syndax Pharmaceuticals (SNDX) Operating Margin (2016 - 2020)
Historic Operating Margin for Syndax Pharmaceuticals (SNDX) over the last 6 years, with Q4 2020 value amounting to 5226.32%.
- Syndax Pharmaceuticals' Operating Margin fell 14881600.0% to 5226.32% in Q4 2020 from the same period last year, while for Dec 2020 it was 4708.17%, marking a year-over-year decrease of 9152300.0%. This contributed to the annual value of 1434.43% for FY2024, which is N/A changed from last year.
- According to the latest figures from Q4 2020, Syndax Pharmaceuticals' Operating Margin is 5226.32%, which was down 14881600.0% from 5238.26% recorded in Q3 2020.
- In the past 5 years, Syndax Pharmaceuticals' Operating Margin registered a high of 1633.61% during Q4 2017, and its lowest value of 5238.26% during Q3 2020.
- Over the past 5 years, Syndax Pharmaceuticals' median Operating Margin value was 4351.46% (recorded in 2017), while the average stood at 4195.8%.
- Per our database at Business Quant, Syndax Pharmaceuticals' Operating Margin skyrocketed by 297691800bps in 2016 and then tumbled by -34540200bps in 2018.
- Over the past 5 years, Syndax Pharmaceuticals' Operating Margin (Quarter) stood at 3652.79% in 2016, then surged by 55bps to 1633.61% in 2017, then plummeted by -211bps to 5087.63% in 2018, then rose by 27bps to 3738.16% in 2019, then crashed by -40bps to 5226.32% in 2020.
- Its Operating Margin was 5226.32% in Q4 2020, compared to 5238.26% in Q3 2020 and 4382.59% in Q2 2020.